National Institutes of Health to Grant Exclusive License for Cancer Treatment Gossypol Acetic Acid

Summary

The National Institutes of Health is considering granting an exclusive worldwide license to IVAX Corporation to use Gossypol Acetic Acid for cancer treatment, following a revision of a previous license to Cary Medical Corporation, as outlined in the Federal Register.